Transplacental passage of ampicillin: Implications for antenatal therapy
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Universitätsklinikum Jena
- Bundesministerium für Forschung, Technologie und Raumfahrt (01GR2305A)
This publication has 47 references indexed in Scilit:
- Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro studyBiomedicine & Pharmacotherapy, 2024
- Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysisAmerican Journal of Obstetrics & Gynecology MFM, 2023
- Therapeutic concentration of ciprofloxacin and transfer across the human term placentaAmerican Journal of Obstetrics and Gynecology, 2021
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#Intensive Care Medicine, 2020
- Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B StreptococcusAmerican Journal of Obstetrics and Gynecology, 2006
- On the absorption and metabolism of35S-ampicillinEuropean Journal of Clinical Pharmacology, 1975
- Transfer across the perfused human placenta of antipyrine, sodium, and leucineAmerican Journal of Obstetrics and Gynecology, 1972
- Placentapassage von Ampizillin in die Frucht zur Behandlung von Listerioseinfektionen in der SchwangerschaftArchives of Gynecology and Obstetrics, 1968
- Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancyAmerican Journal of Obstetrics and Gynecology, 1966
- Placental transfer of ampicillinAmerican Journal of Obstetrics and Gynecology, 1966